SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Aarnoutse R. E.)
 

Search: WFRF:(Aarnoutse R. E.) > (2019) > Management of patie...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Management of patients with multidrug-resistant tuberculosis

Lange, C. (author)
Karolinska Institutet,Res Ctr Borstel, Germany; Univ Lubeck, Germany; German Ctr Infect Res DZIF, Germany; Karolinska Inst, Sweden
Aarnoutse, R. E. (author)
Radboud Univ Nijmegen, Netherlands,Otto Wagner Hosp Vienna, Austria
Alffenaar, J. W. C. (author)
Univ Groningen, Netherlands,Ctr Hosp Leiria, Portugal; Ctr Innovat Technol and Hlth Care, Portugal
show more...
Bothamley, G. (author)
Homerton Univ Hosp, England; QMUL, England; London Sch Hyg and Trop Med, England
Brinkmann, F. (author)
Ruhr Univ Bochum, Germany
Costa, J. (author)
Ctr Hosp Leiria, Portugal; Ctr Innovat Technol and Hlth Care, Portugal
Chesov, D. (author)
Nicoale Testemitanu State Univ Med and Pharm, Moldova; Res Ctr Borstel, Germany
van Crevel, R. (author)
Radboud Univ Nijmegen, Netherlands; Univ Oxford, England
Dedicoat, M. (author)
Univ Hosp Birmingham, England
Dominguez, J. (author)
Univ Autonoma Barcelona, Spain
Duarte, R. (author)
Portuguese Natl TB Program, Portugal; Ctr Hosp Vila Nova de Gaia, Portugal; Univ Porto, Portugal; Univ Porto, Portugal
Grobbel, H. P. (author)
Res Ctr Borstel, Germany; Univ Lubeck, Germany; German Ctr Infect Res DZIF, Germany
Guenther, G. (author)
Res Ctr Borstel, Germany; Univ Namibia, Namibia,St Petersburg State Res Inst Phthisiopulmonol, Russia
Guglielmetti, L. (author)
Hop Univ Pitie Salpetriere Charles Foix, France; Univ Pierre and Marie Curie 06, France
Heyckendorf, J. (author)
Res Ctr Borstel, Germany; Univ Lubeck, Germany; German Ctr Infect Res DZIF, Germany
Kay, A. W. (author)
Texas Childrens Hosp, TX 77030 USA; Baylor Coll Med, TX 77030 USA; Baylor Coll Med Childrens Fdn, Swaziland
Kirakosyan, O. (author)
MSF France OCP, Armenia
Kirk, O. (author)
Univ Copenhagen, Denmark; Univ Southern Denmark, Denmark
Koczulla, R. A. (author)
Philipps Univ Marburg, Germany; German Ctr Lung Res DZL, Germany
Kudriashov, G. G. (author)
St Petersburg State Res Inst Phthisiopulmonol, Russia
Kuksa, L. (author)
Riga East Univ Hosp, Latvia; Riga Stradins Univ, Latvia
van Leth, F. (author)
Univ Amsterdam, Netherlands
Magis-Escurra, C. (author)
Radboud Univ Nijmegen, Netherlands
Mandalakas, A. M. (author)
Texas Childrens Hosp, TX 77030 USA; Baylor Coll Med, TX 77030 USA
Molina-Moya, B. (author)
Univ Autonoma Barcelona, Spain
Peloquin, C. A. (author)
Univ Florida, FL USA
Reimann, M. (author)
Res Ctr Borstel, Germany; Univ Lubeck, Germany; German Ctr Infect Res DZIF, Germany
Rumetshofer, R. (author)
Otto Wagner Hosp Vienna, Austria
Schaaf, H. S. (author)
Stellenbosch Univ, South Africa
Schön, Thomas (author)
Linköpings universitet,Avdelningen för mikrobiologi, infektion och inflammation,Medicinska fakulteten,Kalmar Cty Hosp, Sweden
Tiberi, S. (author)
Barts Hlth NHS Trust, England; Queen Mary Univ, England
Valda, J. (author)
Otto Wagner Hosp Vienna, Austria
Yablonskii, P. K. (author)
St Petersburg State Res Inst Phthisiopulmonol, Russia; St Petersburg State Univ, Russia
Dheda, K. (author)
Univ Cape Town, South Africa
show less...
 (creator_code:org_t)
INT UNION AGAINST TUBERCULOSIS LUNG DISEASE (I U A T L D), 2019
2019
English.
In: The International Journal of Tuberculosis and Lung Disease. - : INT UNION AGAINST TUBERCULOSIS LUNG DISEASE (I U A T L D). - 1027-3719 .- 1815-7920. ; 23:6, s. 645-662
Related links:
https://repository.u...
show more...
https://urn.kb.se/re...
https://doi.org/10.5...
http://kipublication...
show less...
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • The emergence of multidrug-resistant tuberculosis (MDR-TB; defined as resistance to at least rifampicin and isoniazid) represents a growing threat to public health and economic growth. Never before in the history of mankind have more patients been affected by MDR-TB than is the case today. The World Health Organization reports that MDR-TB outcomes are poor despite staggeringly high management costs. Moreover, treatment is prolonged, adverse events are common, and the majority of affected patients do not receive adequate treatment. As MDR-TB strains are often resistant to one or more second-line anti-TB drugs, in-depth genotypic and phenotypic drug susceptibility testing is needed to construct personalised treatment regimens to improve treatment outcomes. For the first time in decades, the availability of novel drugs such as bedaquiline allow us to design potent and well-tolerated personalised MDR-TB treatment regimens based solely on oral drugs. In this article, we present management guidance to optimise the diagnosis, algorithm-based treatment, drug dosing and therapeutic drug monitoring, and the management of adverse events and comorbidities, associated with MDR-TB. We also discuss the role of surgery, physiotherapy, rehabilitation, palliative care and smoking cessation in patients with MDR-TB. We hope that incorporating these recommendations into patient care will be helpful in optimising treatment outcomes, and lead to more MDR-TB patients achieving a relapse-free cure.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Lungmedicin och allergi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Respiratory Medicine and Allergy (hsv//eng)

Keyword

MDR-TB; RESIST-TB; TBNET; TB; XDR-TB; personalised treatment

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view